Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of Alzheimer's disease and dementia
To assess the benefits for positron emission tomography (PET) scanning in patients with dementia, in patients with mild cognitive impairment, and in asymptomatic patients with a family history of Alzheimer's disease (AD), subsequent to the standard evaluation as described in the American Academ...
| Otros Autores: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Durham, NC :
Duke Evidence-Based Practice Center, Center for Clinical Health Policy Research
2001.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820263506719 |
| Sumario: | To assess the benefits for positron emission tomography (PET) scanning in patients with dementia, in patients with mild cognitive impairment, and in asymptomatic patients with a family history of Alzheimer's disease (AD), subsequent to the standard evaluation as described in the American Academy of Neurology (AAN) guidelines. The assessment was done by reviewing the scientific evidence regarding the performance of PET, the natural history of AD, and the treatment efficacy and adverse effects of PET, and by creating a decision model linking testing with treatment and outcome. PET was used as a prototype for a neuroimaging test; however, the model can be applied to a broad range of neuroimaging modalities and treatments. |
|---|---|
| Descripción Física: | 1 online resource |
